Tasigna

nilotinib · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

68 regulatory and trial events tracked for Tasigna, covering 2007-10-29 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors [Phase 1]